congenital heart disease in pregnancy for patients

104
Hello. I would like to think everyone for coming this morning. I’m going to talk about heart disease in pregnancy. 1

Upload: others

Post on 07-Nov-2021

6 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Congenital Heart Disease in Pregnancy for Patients

Hello. I would like to think everyone for coming this morning. I’m going to talk about heart disease in pregnancy.

1

Page 2: Congenital Heart Disease in Pregnancy for Patients

I have a few objectives for this talk. First, we’ll review the normal, anticipated chambers of pregnancy. I am going to discuss how you evaluate a pregnant patient with cardiac disease. Brief review of specific cardiac conditions and will conclude on anticoagulation for the pregnant and a few medications.

2

Page 3: Congenital Heart Disease in Pregnancy for Patients

3

Page 4: Congenital Heart Disease in Pregnancy for Patients

4

Page 5: Congenital Heart Disease in Pregnancy for Patients

5

Page 6: Congenital Heart Disease in Pregnancy for Patients

6

Page 7: Congenital Heart Disease in Pregnancy for Patients

7

Page 8: Congenital Heart Disease in Pregnancy for Patients

8

Page 9: Congenital Heart Disease in Pregnancy for Patients

9

Page 10: Congenital Heart Disease in Pregnancy for Patients

There are several anticipated changes with pregnancy including increase in plasma volume and a lesser degree of increase in red blood cell mass resulting in a mild net anemia, diastolic chamber enlargement, hormone mediated changes in the arteries and veins resulting in increased chamber enlargement, increases in heart rate and cardiac output. 

10

Page 11: Congenital Heart Disease in Pregnancy for Patients

On this graph we have the percent increase in plasma volume on the y‐axis and time on the x‐axis. Plasma volume really starts to increase around 6 to 8 weeks of gestation, peaks at 32. Increases by almost 50% of non‐pregnant values up to a liter to a liter and a half. The exact mechanism is not known but it its thought that it may be impart due nitric oxide mediated vasodilation and changes in vascular compliance leading to stimulation renin‐angiotensin‐aldosterone. This increase is possibly adaptive in reducing hemodynamic instability after blood loss

11

Page 12: Congenital Heart Disease in Pregnancy for Patients

On this graph we have the percent increase in plasma volume on the y‐axis and time on the x‐axis. Plasma volume really starts to increase around 6 to 8 weeks of gestation, peaks at 32. Increases by almost 50% of non‐pregnant values up to a liter to a liter and a half. The exact mechanism is not known but it its thought that it may be impart due nitric oxide mediated vasodilation and changes in vascular compliance leading to stimulation renin‐angiotensin‐aldosterone. This increase is possibly adaptive in reducing hemodynamic instability after blood loss

12

Page 13: Congenital Heart Disease in Pregnancy for Patients

13

Page 14: Congenital Heart Disease in Pregnancy for Patients

Histologic and echocardiographic studies indicate that ventricular wall muscle mass and end‐diastolic volume increase in pregnancy without an associated increase in end‐systolic volume or end‐diastolic pressure.[8,9] Ventricular mass increases in the first trimester, whereas end‐diastolic volume increases in the second and early third trimesters.[8,10] This increases cardiac compliance (resulting in a physiologically dilated heart) without a concomitant reduction in ejection fraction, implying that myocardial contractility must also increase. A recent echocardiographic study of left ventricular function during pregnancy suggests that changes in long‐axis performance occur earlier than changes in transverse function and challenges the notion of dominance of circumferential fiber shortening.

14

Page 15: Congenital Heart Disease in Pregnancy for Patients

30 year old not pregnant

15

Page 16: Congenital Heart Disease in Pregnancy for Patients

33 yo female who is 25 weeks pregnant

16

Page 17: Congenital Heart Disease in Pregnancy for Patients

A general softening of collagen occurs in the entire vascular system, associated with hypertrophy of the smooth muscle component. This results in increased compliance of arteries and veins is evident as early as at 5 weeks of the beginning of amenorrhea

17

Page 18: Congenital Heart Disease in Pregnancy for Patients

18

Page 19: Congenital Heart Disease in Pregnancy for Patients

19

Page 20: Congenital Heart Disease in Pregnancy for Patients

20

Page 21: Congenital Heart Disease in Pregnancy for Patients

On the vertical axis there we have cardiac output and we can see the overall increase in most notably uterine blood flow both in absolute terms and as a fraction of total cardiac output increasing from 2% in the non‐pregnant state to 15‐20% by the 3rd trimester. There are smaller increases to the skin and breasts as well.

21

Page 22: Congenital Heart Disease in Pregnancy for Patients

22

Page 23: Congenital Heart Disease in Pregnancy for Patients

Maternal posture significantly affects cardiac output. Turning from the left lateral recumbent to the supine position at term can result in a drop in cardiac output by as much as 25% to 30%. This is the result of caval compression by the gravid uterus, which diminishes venous return from the lower extremities, decreasing stroke volume and cardiac output. Although most women do not become hypotensive with this maneuver, up to 8% of women do demonstrate the supine hypotensive syndrome, which is manifested by a sudden drop in blood pressure, bradycardia, and syncope.

[At the bottom of the graph, the changes in systolic (open triangles) and diastolic (closed triangles) blood pressures produced by movement from the left lateral recumbent to the supine position are shown.]

23

Page 24: Congenital Heart Disease in Pregnancy for Patients

First stage of labor is early labor. Second stage is the actual delivery of the child. Third is the delivery of the placenta. Because of the severe changes in the second stage, invasive monitoring and assistance is indicated in at risk patients.First stage of labor, CO increases 12‐31%

22% increase in stroke volumeSecond stage of labor, CO increases 49%

Laboring in the left lateral decubitus position or analgesia decreases thisPartially due to painPartially due to painUterine contractions transfer 300‐500 mL of blood from the uterus to the general circulationTransiently increase in SBP (35 mmHg) and DBP (25 mmHg)

24

Page 25: Congenital Heart Disease in Pregnancy for Patients

Anxiety, pain, and uterine contractions all alter hemodynamics.

25

Page 26: Congenital Heart Disease in Pregnancy for Patients

26

Page 27: Congenital Heart Disease in Pregnancy for Patients

First stage of labor is early labor. Second stage is the actual delivery of the child. Third is the delivery of the placenta. Because of the severe changes in the second stage, invasive monitoring and assistance is indicated in at risk patients.Rapid increase in ventricular end diastolic volume and end diastolic pressure

27

Page 28: Congenital Heart Disease in Pregnancy for Patients

28

Page 29: Congenital Heart Disease in Pregnancy for Patients

Dyspnea with increased frequency as gestation advances (15% in the first trimester compared with 75% by the third). The mechanism for this is unclear, but it may relate to the exaggerated ventilatory response (perhaps progesterone mediated)

Mild to moderate execise should still be well tolerated 

29

Page 30: Congenital Heart Disease in Pregnancy for Patients

30

Page 31: Congenital Heart Disease in Pregnancy for Patients

31

Page 32: Congenital Heart Disease in Pregnancy for Patients

32

Page 33: Congenital Heart Disease in Pregnancy for Patients

33

Page 34: Congenital Heart Disease in Pregnancy for Patients

34

Page 35: Congenital Heart Disease in Pregnancy for Patients

35

Page 36: Congenital Heart Disease in Pregnancy for Patients

36

Page 37: Congenital Heart Disease in Pregnancy for Patients

37

Page 38: Congenital Heart Disease in Pregnancy for Patients

38

Page 39: Congenital Heart Disease in Pregnancy for Patients

39

Page 40: Congenital Heart Disease in Pregnancy for Patients

60% of subjects were randomized to derivation and 40% to validation.

40

Page 41: Congenital Heart Disease in Pregnancy for Patients

41

Page 42: Congenital Heart Disease in Pregnancy for Patients

60% of subjects were randomized to derivation and 40% to validation.

42

Page 43: Congenital Heart Disease in Pregnancy for Patients

43

Page 44: Congenital Heart Disease in Pregnancy for Patients

2006 Article by Paul Kheiry and Michael Lansberg of 90 pregancies of women with CHD at Bringham & Womens Hospital between 98‐2004.

44

Page 45: Congenital Heart Disease in Pregnancy for Patients

45

Page 46: Congenital Heart Disease in Pregnancy for Patients

The modified risk score for cardiac complications during completed (>20 weeks of gestation) pregnancies in women with congenital heart diseaseweeks of gestation) pregnancies in women with congenital heart disease (expressed as % of the total number of completed pregnancies). AV, atrioventricular; AVA, aortic valve area; LHO, left heart obstruction; NYHA, New York Heart Association; PG, peak gradient; Pulm, pulmonary; Syst, systemic.

Page 47: Congenital Heart Disease in Pregnancy for Patients

47

Page 48: Congenital Heart Disease in Pregnancy for Patients

48

Page 49: Congenital Heart Disease in Pregnancy for Patients

49

Page 50: Congenital Heart Disease in Pregnancy for Patients

50

Page 51: Congenital Heart Disease in Pregnancy for Patients

51

Page 52: Congenital Heart Disease in Pregnancy for Patients

52

Page 53: Congenital Heart Disease in Pregnancy for Patients

ASD, even large defects, generally well tolerated except in pulmonary hypertension or atrial fibrillation. Risk of paradoxic embolism is increased during pregnancy.

53

Page 54: Congenital Heart Disease in Pregnancy for Patients

54

Page 55: Congenital Heart Disease in Pregnancy for Patients

Beta blockers help by increasing diastolic filling time. Council against pregnancy in Severe AS.  Balloon valvuloplasty can be considered with shielding of the gravid uterus. Pulmonary stenosis is usually well tolerated unless RV hypertension is present.

55

Page 56: Congenital Heart Disease in Pregnancy for Patients

56

Page 57: Congenital Heart Disease in Pregnancy for Patients

57

Page 58: Congenital Heart Disease in Pregnancy for Patients

58

Page 59: Congenital Heart Disease in Pregnancy for Patients

59

Page 60: Congenital Heart Disease in Pregnancy for Patients

The largest series published retrospectively reviewed 44 women with 70 pregnancies, and 52% of women died in connection with a pregnancy.A smaller more recent series of 12 patients, three spontaneous abortions (early), two still births, Eight born; five premature. Three mothers died. Pulmonary infarct or RV failure.ICU delivery with invasive pressure monitoring, left lateral decubitus positioning may be helpful. Copious LE care for DVT. Low dose heparin is controversial. 

60

Page 61: Congenital Heart Disease in Pregnancy for Patients

61

Page 62: Congenital Heart Disease in Pregnancy for Patients

62

Page 63: Congenital Heart Disease in Pregnancy for Patients

63

Page 64: Congenital Heart Disease in Pregnancy for Patients

Highly variable risk, most authors estimate 5‐6%Chondrodysplasia punctataLess risk if daily dose <5

64

Page 65: Congenital Heart Disease in Pregnancy for Patients

65

Page 66: Congenital Heart Disease in Pregnancy for Patients

66

Page 67: Congenital Heart Disease in Pregnancy for Patients
Page 68: Congenital Heart Disease in Pregnancy for Patients

68

Page 69: Congenital Heart Disease in Pregnancy for Patients

69

Page 70: Congenital Heart Disease in Pregnancy for Patients

70

Page 71: Congenital Heart Disease in Pregnancy for Patients

71

Page 72: Congenital Heart Disease in Pregnancy for Patients

72

Page 73: Congenital Heart Disease in Pregnancy for Patients

73

Page 74: Congenital Heart Disease in Pregnancy for Patients

74

Page 75: Congenital Heart Disease in Pregnancy for Patients

75

Page 76: Congenital Heart Disease in Pregnancy for Patients

76

Page 77: Congenital Heart Disease in Pregnancy for Patients

77

Page 78: Congenital Heart Disease in Pregnancy for Patients

Insert echo or MRI of BAV vs trileaflet

78

Page 79: Congenital Heart Disease in Pregnancy for Patients

79

Page 80: Congenital Heart Disease in Pregnancy for Patients

80

Page 81: Congenital Heart Disease in Pregnancy for Patients

81

Page 82: Congenital Heart Disease in Pregnancy for Patients

82

Page 83: Congenital Heart Disease in Pregnancy for Patients

83

Page 84: Congenital Heart Disease in Pregnancy for Patients

84

Page 85: Congenital Heart Disease in Pregnancy for Patients

85

Page 86: Congenital Heart Disease in Pregnancy for Patients

86

Page 87: Congenital Heart Disease in Pregnancy for Patients

87

Page 88: Congenital Heart Disease in Pregnancy for Patients

88

Page 89: Congenital Heart Disease in Pregnancy for Patients

89

Page 90: Congenital Heart Disease in Pregnancy for Patients

90

Page 91: Congenital Heart Disease in Pregnancy for Patients

91

Page 92: Congenital Heart Disease in Pregnancy for Patients

92

Page 93: Congenital Heart Disease in Pregnancy for Patients

93

Page 94: Congenital Heart Disease in Pregnancy for Patients

94

Page 95: Congenital Heart Disease in Pregnancy for Patients

95

Page 96: Congenital Heart Disease in Pregnancy for Patients

96

Page 97: Congenital Heart Disease in Pregnancy for Patients

97

Page 98: Congenital Heart Disease in Pregnancy for Patients

98

Page 99: Congenital Heart Disease in Pregnancy for Patients

99

Page 100: Congenital Heart Disease in Pregnancy for Patients

100

Page 101: Congenital Heart Disease in Pregnancy for Patients

101

Page 102: Congenital Heart Disease in Pregnancy for Patients

102

Page 103: Congenital Heart Disease in Pregnancy for Patients

103

Page 104: Congenital Heart Disease in Pregnancy for Patients

104